NOBIVAC RABIES Ireland - English - HPRA (Health Products Regulatory Authority)

nobivac rabies

intervet ireland limited - rabies virus strain pasteur riv inactivated - suspension for injection - unknown - rabies virus vaccine - canine, feline - immunological - inactivated vaccine

IMOVAX RABIES (rabies virus strain pm-1503-3m antigen- propiolactone inactivated and water kit United States - English - NLM (National Library of Medicine)

imovax rabies (rabies virus strain pm-1503-3m antigen- propiolactone inactivated and water kit

sanofi pasteur inc. - rabies virus strain pm-1503-3m antigen (propiolactone inactivated) (unii: c4hqf74xmw) (rabies virus strain pm-1503-3m antigen (propiolactone inactivated) - unii:c4hqf74xmw) - rabies virus strain pm-1503-3m antigen (propiolactone inactivated) 2.5 [iu] in 1 ml - imovax rabies is a vaccine indicated for pre-exposure and post-exposure prophylaxis against rabies. imovax rabies vaccine is approved for use in all age groups. physicians must evaluate each possible rabies exposure. local or state public health officials should be consulted if questions arise about the need for prophylaxis. (11) the following factors should be considered before antirabies prophylaxis is initiated. rabid bats have been documented in the 49 continental states, and bats are increasingly implicated as important wildlife reservoirs for variants of rabies virus transmitted to humans. transmission of rabies virus can occur from minor, seemingly underappreciated or unrecognized bites from bats (see table 2). (11) raccoons, skunks, and foxes are the terrestrial carnivores most often infected with rabies in the united states. suggestive clinical signs of rabies among wildlife cannot be interpreted reliably. all bites by such wildlife should be considered possible exposures to rabies virus. post-exposu

Rabies Vaccine BP > 2.5 IU/ml, Powder and solvent for suspension for injection Ireland - English - HPRA (Health Products Regulatory Authority)

rabies vaccine bp > 2.5 iu/ml, powder and solvent for suspension for injection

sanofi pasteur - inactivated rabies virus strain pm/wi 38 1503 3m - powder and solvent for suspension for injection - 2.5 international unit(s)/millilitre - rabies vaccines; rabies, inactivated, whole virus

Nobivac Rabies Ireland - English - HPRA (Health Products Regulatory Authority)

nobivac rabies

intervet ireland limited - inactivated rabies virus antigen suspension - suspension for injection - 2-6 international units/dose - rabies virus - cats, dogs - immunological - inactivated vaccine

Nobivac Rabies Formulation:   Each 1 mL (dose) contains:   Rabies Virus (Pasteur RIV Strain).............. > 2I.U. IU-International Units Suspension for Injection (SC/IM) Philippines - English - FDA (Food And Drug Administration)

nobivac rabies formulation: each 1 ml (dose) contains: rabies virus (pasteur riv strain).............. > 2i.u. iu-international units suspension for injection (sc/im)

msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - inactivated rabies virus vaccine (vet.) - suspension for injection (sc/im) - formulation: each 1 ml (dose) contains: rabies virus (pasteur riv strain).............. > 2i.u. iu-international units

Inactivated Rabies Vaccine Merieux HDCV inj. sol. (pwdr. + solv.) i.m. vial + pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

inactivated rabies vaccine merieux hdcv inj. sol. (pwdr. + solv.) i.m. vial + pre-filled syr.

sanofi pasteur europe s.a. - rabies virus (inactivated) ; albumin human 50 mg - powder and solvent for solution for injection - rabies virus, inactivated - rabies, inactivated, whole virus

IMOGAM RABIES-HT- human rabies virus immune globulin injection, solution United States - English - NLM (National Library of Medicine)

imogam rabies-ht- human rabies virus immune globulin injection, solution

sanofi pasteur inc. - human rabies virus immune globulin (unii: 95f619atq2) (human rabies virus immune globulin - unii:95f619atq2) - human rabies virus immune globulin 150 [iu] in 1 ml - rabies immune globulin (human) heat treated, imogam rabies – ht, in conjunction with the standard series of rabies vaccine vaccinations, is indicated for individuals suspected of exposure to rabies, particularly severe exposure, with one exception: persons who have been previously immunized with rabies vaccine. previously immunized persons are those who have had a documented rabies virus neutralizing antibody titer and who have completed one of the recommended regimens (pre-exposure or post-exposure) with a cell culture vaccine or another vaccine. administer only vaccine to these persons (i.e., post-exposure for a person previously vaccinated). (1) inject imogam rabies – ht, as promptly as possible after exposure, along with the first dose of vaccine. if initiation of treatment is delayed for any reason, still administer imogam rabies – ht and the first dose of vaccine, regardless of the interval between exposure and treatment. if rabies immune globulin (human) was not administered when vaccination was begun

Nobivac Rabies New Zealand - English - Ministry for Primary Industries

nobivac rabies

schering-plough animal health limited - rabies virus (inactivated) - rabies virus (inactivated) 0 vaccine - vaccine

Merieux Inactivated Rabies Vaccine (MIRV) New Zealand - English - Medsafe (Medicines Safety Authority)

merieux inactivated rabies vaccine (mirv)

pharmacy retailing (nz) ltd t/a healthcare logistics - rabies vaccine, wistar pm/wi 38-1503-3m 2.5 [iu] - suspension for injection - 2.5 iu - active: rabies vaccine, wistar pm/wi 38-1503-3m 2.5 [iu] excipient: albumin neomycin sulfate water for injection - post exposure immunisation against rabies. pre-exposure immunisation in persons at special risk of contracting rabies.